Log in to save to my catalogue

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70878139

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption

About this item

Full title

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption

Author / Creator

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

Journal title

Current pharmaceutical design, 2001-05, Vol.7 (8), p.613-635

Language

English

Formats

Publication information

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

OPG is a new member of the tumor necrosis factor (TNF) receptor family which plays a key role in the physiological regulation of osteoclastic bone resorption. The protein, which is produced by osteoblasts and marrow stromal cells, lacks a transmembrane domain and acts as a secreted decoy receptor which has no direct signaling capacity. OPG acts by...

Alternative Titles

Full title

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_70878139

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70878139

Other Identifiers

ISSN

1381-6128

E-ISSN

1873-4286

DOI

10.2174/1381612013397807

How to access this item